Home > Updates
Updates
- Sep. 12, 2024
- Investigator-initiated clinical studies to be launched following confirmation of tumor shrinkage induced by the targeted protein degrader E7820 using J-PDX (Japanese cancer patient-derived tissue transplantation models)
- Jul. 11, 2024
- Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)
- Jun. 10, 2024
- Dutch-Japanese workshop 'AI for Health' held
- Jun. 10, 2024
- Dr Tatsuhiro Shibata nominated Scientific Council Member of IARC
- May 14, 2024
- World’s Largest Whole Genome Sequencing of Renal Cancer:
mutational signature linked to an unknown exposure discovered in 70% of Japanese samples - Jan. 12, 2024
- Team explores role of STING – stimulator of interferon genes – in body’s innate immune system
- Nov. 21, 2023
- Researchers from National Cancer Center on ‘Highly Cited Researchers 2023’ List
- Sep. 22, 2023
- Driving Japan-US Collaboration in Oncology
- Sep. 20, 2023
- Research agreement on CAR-T cancer treatment development concluded between National Cancer Center and Asahi Kasei
- Sep. 14, 2023
- Our Research Institute is now introduced in the Nature Cancer Index in the 7 September 2023 issue of Nature.
- Jun. 12, 2023
- Announcing the approval of the apolipoprotein A2 isoform index for in vitro diagnostics in Japan
- Apr. 10, 2023
- Efficacy of Anti-HER2 Therapy with Trastuzumab Deluxecan in Uterine Carcinosarcoma Consistent with PDX-model predictions of efficacy, paving the way for the development of treatments for rare cancers.
- Mar. 14, 2023
- World’s Largest Gastric Cancer Genomic Study Reveals Treatment Targets for Japanese Patients Alcohol intake link gives hope for improving prevention strategies
- Jan. 5, 2023
- Moonshot Research and Development Program ‘Actualization of a cancer-free society through regulation of chronic inflammation’ launched
- Nov. 18, 2022
- Researchers from National Cancer Center on ‘Highly Cited Researchers 2022’ List
- Oct. 7, 2022
- Fusion genes as drug resistance in EGFR mutant lung cancer
- Sep. 27, 2022
- Study pinpoints origin of pediatric brain tumour and shows it may be preventable
- Aug. 8, 2022
- American Society of Hematology Confers Akihide Yoshimi the Global Research Award
- Aug. 8, 2022
- Akihide Yoshimi, Section Head of Cancer RNA Research Unit, Research Institute was Awarded the ASH Global Research Award 2022
- Jul. 11, 2022
- Franco-Japanese immuno-oncology webinar 4st session held
- Jul. 1, 2022
- Utility of gene panel testing for comprehensive genomic profiling of blood cancers demonstrated
- May 25, 2022
- Franco-Japanese immuno-oncology webinar 3rd session held
- May 25, 2022
- Cooperation with the U.S. National Cancer Institute welcomed by Japan-US leaders in joint statement- role of National Cancer Center highlighted
- Apr. 12, 2022
- Hiroyoshi Nishikawa honored with a prestigious Commendation from the Minister of Education, Culture, Sports, Science and Technology
- Mar. 25, 2022
- Franco-Japanese immuno-oncology webinar 2st session held
- Mar. 18, 2022
- Aberrant activation of cell cycle-related kinases in uterine leiomyosarcoma
- Mar. 3, 2022
- Discovery of splicing vulnerability and novel therapy in RAS Q61 cancers -Nature-
- Feb. 1, 2022
- Recruitment of Postdoctoral Fellow
- Jan. 28, 2022
- Franco-Japanese immuno-oncology webinar 1st session held
- Jan. 28, 2022
- Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
- Jan. 18, 2022
- Tatsuhiro Shibata awarded Princess Takamatsu Cancer Research Fund Prize
- Dec. 24, 2021
- Depletion of central memory CD8+T cells might impede the antitumor therapeutic effect of Mogamulizumab
- Oct. 28, 2021
- Unveiling the Landscape of Genomic Alterations in Adult T-Cell Leukemia/Lymphoma
- Oct. 27, 2021
- Global whole genome sequencing research on esophageal cancers reveals
carcinogenic mechanisms specific to Japan - Oct. 14, 2021
- Breakthrough Discovery on the Structure and Activation Mechanism of ALK
- Sep. 6, 2021
- Molecular landscape of multi-step virus carcinogenesis revealed by multi-modal single-cell analysis
- Aug. 17, 2021
- Whole Genome Sequencing Finds Therapeutic Targets for Linitis Plastica-type Gastric Cancer
- Jun. 2, 2021
- SARS-CoV-2 antibody status in patients with cancer during the COVID-19 pandemic in Japan
- May 14, 2021
- NATIONAL CANCER CENTER AND EISAI COMMENCE JOINT RESEARCH AND DEVELOPMENT PROJECT “BASIC RESEARCH ON THE DRUG DISCOVERY AND DEVELOPMENT TO ACCELERATE DEVELOPMENT OF ANTICANCER DRUGS IN TREATMENT OF PATIENTS WITH RARE CANCERS AND REFRACTORY CANCERS”, USING PDX WITH HIGH PREDICTABILITY OF CLINICAL OUTCOMES, AND CANCER GENOME DATA
- Apr. 9, 2021
- Dr Hiroyuki Mano was awarded the 49th Fondation ARC Leopold Griffuel Prize for Clinical and Translational Cancer Research
- Nov. 25, 2020
- Hiroyoshi Nishikawa Elected AAAS Fellow
- Nov. 17, 2020
- Hiroyoshi Nishikawa Honoured with the 2020 SITC ‘Team Science Award’
- Sep. 1, 2020
- A novel biomarker for predicting clinical efficacy of PD-1 blockade therapies
- Aug. 20, 2020
- NCC joins GSK’s oncology development network
- Jul. 3, 2020
- The National Cancer Center, the National Center for Global Health and Medicine, and Sysmex Corporation Evaluate a SARS-CoV-2 Antibody Test with Support from the Japan Health Research Promotion Bureau
- Mar. 2, 2020
- HE Professor Tomasz Grodzki, Polish Senate Marshal visit
- Feb. 26, 2020
- WHO and IARC Cancer Reports Published
- Feb. 17, 2020
- Global Consortium Completes Tumor Analyses Project
- Jan. 29, 2020
- Clinical Trial Investigators visit NCC Hospital
- Feb. 12, 2019
- UK Genomics Delegation visit
- Oct. 1, 2018
- National Cancer Center Japan and Maruho Enter License Agreement and Research Collaboration Agreement for a Novel Analgesic for Stomatitis in Cancer Treatment
- Jun. 27, 2018
- Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
- May 7, 2018
- National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery
- Feb. 14, 2018
- A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects - Jan. 23, 2018
- Precise cancer risk estimation based upon measurement of mutations and aberrant DNA methylation accumulated in normal tissues
association between the accumulation and life style
